2021

O'Connor, A., Pannee, J., Poole, T., Arber, C., Portelius, E., Swift, I.J., ...Rice, H. (2021). Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype. Brain, doi:10.1093/brain/awab166
Alawode, D.O.T., Heslegrave, A.J., Ashton, N.J., Karikari, T.K., Simrén, J., Montoliu-Gaya, L., ...Lantero-Rodriguez, J. (2021). Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease. Journal of Internal Medicine, doi:10.1111/joim.13332
Pavisic, I.M., Nicholas, J.M., Pertzov, Y., O'Connor, A., Liang, Y., Collins, J.D., ...Husain, M. (2021). Visual short-term memory impairments in presymptomatic familial Alzheimer's disease: A longitudinal observational study. Neuropsychologia, 162 doi:10.1016/j.neuropsychologia.2021.108028
Lu, K., Nicholas, J.M., Weston, P.S.J., Stout, J.C., O’Regan, A.M., James, S.N., ...Keuss, S.E. (2021). Visuomotor integration deficits are common to familial and sporadic preclinical Alzheimer’s disease. Brain Communications, doi:10.1093/braincomms/fcab003

2020

Zetterberg, H., Alawode, D., Keshavan, A., o'connor, A., Weston, P., Paterson, R., ...Schott, J. (2020). Blood Tests for Alzheimer Disease. Practical Neurology,
Weston, P.S.J., Poole, T., Nicholas, J.M., Toussaint, N., Simpson, I.J.A., Modat, M., ...Schott, J.M. (2020). Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer's disease. Alzheimer's Research & Therapy, 12 (1), 112. doi:10.1186/s13195-020-00679-2
O’Connor, A., Karikari, T.K., Poole, T., Ashton, N.J., Lantero Rodriguez, J., Khatun, A., ...Chung, E. (2020). Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study. Molecular Psychiatry, doi:10.1038/s41380-020-0838-x
O’Connor, A., Weston, P.S.J., Pavisic, I.M., Ryan, N.S., Collins, J.D., Lu, K., ...Oxtoby, N.P. (2020). Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis. Alzheimer's Research and Therapy, 12 1-9. doi:10.1186/s13195-020-00695-2

2019

Convery, R.S., Jiao, J., Clarke, M.T.M., Moore, K.M., Koriath, C.A.M., Woollacott, I.O.C., ...Cash, D.M. (2019). Longitudinal (¹⁸F)AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation. Journal of Neurology, Neurosurgery & Psychiatry, doi:10.1136/jnnp-2019-320904
Weston, P.S.J., Poole, T., O'Connor, A., Heslegrave, A., Ryan, N.S., Liang, Y., ...Schott, J.M. (2019). Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease.. Alzheimers Res Ther, 11 (1), 19. doi:10.1186/s13195-019-0472-5

2018

Weston, P.S.J., Poole, T., Ryan, N.S., Nair, A., Liang, Y., Macpherson, K., ...Pemberton, H. (2018). Accelerated long-term forgetting in presymptomatic Autosomal Dominant Alzheimer’s disease: A cross-sectional study. Lancet Neurology, doi:10.1016/S1474-4422(17)30434-9
Weston, P.S.J., Nicholas, J.M., Henley, S.M.D. (2018). Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study (vol 17, pg 123, 2018). LANCET NEUROLOGY, 17 (4), 298.
Paterson, R.W., Slattery, C.F., Poole, T., Nicholas, J.M., Magdalinou, N.K., Toombs, J., ...Foiani, M.S. (2018). Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.. Alzheimer's research & therapy, 10 (1), 32. doi:10.1186/s13195-018-0361-3
Lashley, T., Schott, J.M., Weston, P., Murray, C.E., Wellington, H., Keshavan, A., ...Rohrer, J.D. (2018). Molecular biomarkers of Alzheimer's disease: progress and prospects.. Disease models & mechanisms, 11 (5), doi:10.1242/dmm.031781
Scott, C.J., Jiao, J., Melbourne, A., Burgos, N., Cash, D.M., De Vita, E., ...Weston, P.S. (2018). Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL-MRI: proof of concept. Journal of Cerebral Blood Flow and Metabolism, 271678X18797343. doi:10.1177/0271678X18797343

2017

Weston, P.S.J., Poole, T., Ryan, N.S., Nair, A., Liang, Y., Macpherson, K., ...Pemberton, H. (2017). Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.. Neurology, doi:10.1212/wnl.0000000000004667

2016

Ryan, N.S., Nicholas, J.M., Weston, P.S.J., Liang, Y., Lashley, T., Guerreiro, R., ...Chavez-Gutierrez, L. (2016). Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series. LANCET NEUROLOGY, 15 (13), 1326-1335. doi:10.1016/S1474-4422(16)30193-4
Weston, P.S., Paterson, R.W., Dickson, J., Barnes, A., Bomanji, J.B., Kayani, I., ...Rossor, M.N. (2016). Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?. Journal of Alzheimer's disease : JAD, doi:10.3233/JAD-160302
Jiao, J., Bousse, A., Thielemans, K., Burgos, N., Weston, P., Markiewicz, P., ...Hutton, B. (2016). Direct Parametric Reconstruction with Joint Motion Estimation/Correction for Dynamic Brain PET Data.. IEEE Trans Med Imaging, doi:10.1109/TMI.2016.2594150
Weston, P.S., Nicholas, J.M., Lehmann, M., Ryan, N.S., Liang, Y., Macpherson, K., ...Ourselin, S. (2016). Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.. Neurology, doi:10.1212/WNL.0000000000003322

2015

Weston, P.S.J., Simpson, I.J.A., Ryan, N.S., Ourselin, S., Fox, N.C. (2015). Diffusion imaging changes in grey matter in Alzheimer's disease: a potential marker of early neurodegeneration. ALZHEIMERS RESEARCH & THERAPY, 7 doi:10.1186/s13195-015-0132-3
Weston, P.S.J., Hunter, M.D., Sokhi, D.S., Wilkinson, I.D., Woodruff, P.W.R. (2015). Discrimination of voice gender in the human auditory cortex. NEUROIMAGE, 105 208-214. doi:10.1016/j.neuroimage.2014.10.056
Paterson, R.W., Toombs, J., Chapman, M.D., Nicholas, J.M., Heslegrave, A.J., Slattery, C.F., ...Weston, P.S.J. (2015). Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 1 (3), 380-384. doi:10.1016/j.dadm.2015.06.003
Monserrate, A.E., Ryman, D.C., Ma, S., Xiong, C., Noble, J.M., Ringman, J.M., ...Clifford, D.B. (2015). Factors Associated With the Onset and Persistence of Post-Lumbar Puncture Headache. JAMA NEUROLOGY, 72 (3), 325-332. doi:10.1001/jamaneurol.2014.3974
Weston, P.S.J., Paterson, R.W., Lehmann, M., Modat, M., Bomanji, J.B., Kayani, I., ...Ourselin, S. (2015). USING FLORBETAPIR PET TO INCREASE DIAGNOSTIC CERTAINTY IN ATYPICAL DEMENTIAS.
Weston, P.S., Paterson, R.W., Modat, M., Burgos, N., Cardoso, M.J., Magdalinou, N., ...Bomanji, J.B. (2015). Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 1 (4), 440-446. doi:10.1016/j.dadm.2015.10.001

2014

Weston, P.S.J., Cash, D.M., Ryan, N.S., Leung, K.K., Fox, N. (2014). BRAIN ATROPHY IN MCI AND PRESYMPTOMATIC NEURODEGENERATION: INSIGHTS FROM, AND ADVANTAGES OF, LONGITUDINAL STUDIES.
Weston, P.S.J., Smith, C.A. (2014). The use of mini-CEX in UK foundation training six years following its introduction: Lessons still to be learned and the benefit of formal teaching regarding its utility. MEDICAL TEACHER, 36 (2), 155-163. doi:10.3109/0142159X.2013.836267

2012

Weston, P.S.J., Lim, C.S., Shalhoub, J., Davies, A.H. (2012). Metastatic bladder transitional cell carcinoma presenting as a vascularised cutaneous right arm lesion. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 17 (3), 286-289. doi:10.1007/s10147-011-0282-7

2007

Weston, P.S., Hunter, M.D., Wilkinson, I.D., Woodruff, P.W. (2007). Gender of hallucination-like speech affects auditory cortical response differently in both male and female listeners: A functional magnetic resonance imaging (FMRI) study.

1900

Weston, P.S.J. (1900). Detecting and tracking early neurodegeneration in familial Alzheimer’s disease. (Doctoral Dissertation). UCL (University College London).
Bond, R.L., Downey, L.E., Weston, P.S.J., Slattery, C.F., Clark, C.N., Macpherson, K., ...Warren, J.D. (1900). Processing of Self versus Non-Self in Alzheimer’s Disease. Frontiers in Human Neuroscience, 10 (97), doi:10.3389/fnhum.2016.00097
O'Connor, A., Poole, T., Weston, P., Ryan, N., Liang, Y., Lu, K., ...Blennow, K. (1900). Serum neurofilament light concentration and progression in familial Alzheimer’s diseas. Presented at: Alzheimer's Association International Conference, 2018 Chicago, USA.
Pavisic, I., Pertzov, Y., O'Connor, A., Nicholas, J., Lu, K., Collins, J., ...Yong, K. (1900). Visual Short-Term Binding Deficit in Familial Alzheimer’s Disease: A Longitudinal Study. Presented at: Alzheimer's Association International Conference 2018 Chicago, USA.
Pavisic, I., Pertzov, Y., Nicholas, J., O'Connor, A., Lu, K., Collins, J., ...Yong, K. (1900). Visual short-term memory binding deficits in familial Alzheimer’s disease: A Longitudinal Study. Presented at: Alzheimer's Research UK, 2019 Harrogate, UK.